CAMBRIDGE NUTRITIONAL SCIENCES PLC
("CNS" or the "Company" or the "Group")
CNS continues to expand Scientific Educational Programme and build relationships at leading Industry Events
· Company delivers latest webinar tackling the role of inflammation in irritable bowel syndrome
· Lecture presented in
· CNS continues to raise its profile at key industry events, helping drive demand for products
CNS (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces developments in its scientific education programme, a key initiative which enables the Company to collaborate with a number of global and
Latest Educational Webinar Released: "Inflammation in irritable bowel syndrome: myth or new treatment target"
· Thought-leading topic exploring how food IgG antibodies can activate mast cells in the gut leading to irritable bowel syndrome symptoms.
· In October, CNS's Scientific Director, Dr Nigel Abraham, presented this lecture in person at the International Symposium for food intolerance and Digestive Health ('FIDHC') in
CNS Raises Awareness with Practitioners Through Networking at Leading
Key to CNS's strategy of maintaining a leadership position is building awareness with healthcare practitioners. These events give the company the opportunity to meet and re-engage with practitioner customers as well as those who are new to food sensitivity testing or taking their first steps in clinical practice.
IHCAN 2023 Summit
· CNS's
· Key industry event, attended by approximately 300 integrative health practitioners and guest speakers from around the world.
· Opportunity to explain the clinical utility for the Company's products to future practitioners in the end stages of their training.
· Platform to educate those interested in learning about how embedding food sensitivity testing in their practice can help resolve gut related health issues and improve patient care.
NMI, IPMC, and ION
· The company also attended several other relevant
CNS Builds Business Partner Relationships at Industry Trade Fair
Medica
· In November the Company attended Medica in
Commenting, Jag Grewal, Chief Executive Officer, said:
"Collaboration with global and
"This engagement is critical in our drive to foster strong partnerships with healthcare practitioners and potential business partners. It leads to better awareness and understanding of the Company, which in turn creates demand for our products, and helps cement the Group as a global thought leader in its field."
Contacts:
Cambridge Nutritional Sciences PLC |
||
Jag Grewal, Chief Executive Officer |
via Walbrook PR |
|
|
|
|
Cavendish Capital Markets Limited |
Tel: 020 7220 0500 |
|
Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance) |
|
|
Nigel Birks / Harriet Ward (ECM) |
|
|
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 or omega@walbrookpr.com |
|
Paul McManus / Charlotte Edgar |
Mob: 07980 541 893 / Mob: 07884 664 686 / |
|
Sam Allen |
Mob: 07502 558 258 |
|
|
|
|
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.